COULTREON BIOPHARMA
The computed 12-month bankruptcy probability of COULTREON BIOPHARMA is 1.1% (low). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 1 yrs |
| Board | 3 |
| Locations | 1 |
| Publications | 7 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
-
Current20-11-2025 → present
-
Vuldex Consulting BVLegal entityDirector· perm. rep.: Marie De VulderState Gazette act 25151961 (01-12-2025)Current01-06-2025 → present
-
Pierre Raboisson BVLegal entityManaging director· perm. rep.: Pierre RaboissonState Gazette act 25151961 (01-12-2025)Current01-04-2025 → present
2 events
- 01-06-2025 Appointed· Managing director
- 01-04-2025 Appointed· Director
| NACE primary | Vervaardiging van geneesmiddelen(21201) |
| Legal form | Private limited company(610) |
| Incorporation | 30-01-2025 |
| Status | Active |
| Postal code | 3001 |
Show 2 more network connections
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24040B0218/00V002 | Flanders | 2,297 m² | 1 · 1,484 m² | 2.6 m |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
04-08-2026 Act object · Notarial deed · Incorporation · Founder
- Act object: OPRICHTING · Stichting Administratiekantoor Coultreon
- Publication: 04/08/2026 · Stichting Administratiekantoor Coultreon
- Filing: 31-07-2026 · Stichting Administratiekantoor Coultreon
- Notarial deed: 31-07-2026 · Stichting Administratiekantoor Coultreon
- Incorporation: 31-07-2026 · Stichting Administratiekantoor Coultreon
- Founder · COULTREON BIOPHARMA
- Purpose: De private stichting wordt opgericht ter verwezenlijking van het volgend belangeloos doel: het bevorderen van een stabiel aandeelhouderschap van Coultreon Biopharma, met het oog op een efficiënte en eenvoudige besluitvorming binnen Coultreon Biopharma (waarvan de Aandelen worden gecertificeerd overeenkomstig de voorwaarden zoals bepaald in de Administratievoorwaarden en de Aandeelhoudersovereenkomt). De private stichting beoogt met deze structuur een duurzame scheiding tot stand te brengen tussen de economische gerechtigheid tot de Aandelen en de uitoefening van de daaraan verbonden zeggenschapsrechten. De private stichting zal fungeren als administratiekantoor van de Aandelen van Coultreon Biopharma. · Stichting Administratiekantoor Coultreon
- First fiscal year: 31-12-2027 · Stichting Administratiekantoor Coultreon
- Officer appointment: role: bestuurder, term: onbepaalde duur, start_date: 2026-07-31 · Pierre Raboisson BV
- Permanent representative · Pierre RABOISSON
- Officer appointment: role: bestuurder, term: onbepaalde duur, start_date: 2026-07-31 · Vuldex Consulting BV
- Permanent representative · Marie DE VULDER
- Officer appointment: role: bestuurder, term: onbepaalde duur, start_date: 2026-07-31 · SKJ Consult BV
- Permanent representative · Guy PEETERS
- Mandate compensation: onbezoldigd · Pierre Raboisson BV
- Mandate compensation: onbezoldigd · Vuldex Consulting BV
- Mandate compensation: onbezoldigd · SKJ Consult BV
- Filing representative: vervulling van de formaliteiten bij het rechtspersonenregister alsook bij een ondernemingsloket met het oog op de inschrijving van de gegevens van de private stichting in de Kruispuntbank van Ondernemingen · Osborne Clarke BV
- Filing representative: het verkrijgen van de rechtspersoonlijkheid van de vereniging en de publicatie van de statuten in de Bijlagen bij het Belgisch Staatsblad · Berquin Notarissen
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Onderwerp akte : OPRICHTING",
"value": "OPRICHTING",
"object": null,
"subject": "e1"
},
{
"date": "2026-08-04",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 04/08/2026",
"value": "04/08/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-31",
"type": "filing",
"quote": "Neergelegd 31-07-2026",
"value": "31-07-2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-31",
"type": "notarial_deed",
"quote": "Het jaar tweeduizend zesentwintig. Op eenendertig juli. (...) Voor mij, Tim CARNEWAL, notaris te Brussel",
"value": "31-07-2026",
"object": "e10",
"subject": "e1"
},
{
"date": "2026-07-31",
"type": "incorporation",
"quote": "Het jaar tweeduizend zesentwintig. Op eenendertig juli. (...) IS VERSCHENEN: de besloten vennootschap \u0022COULTREON BIOPHARMA\u0022 (...) Die mij notaris, gevraagd heeft bij authentieke akte de oprichting en de statuten vast te stellen van de hierna genoemde private stichting",
"value": "31-07-2026",
"object": null,
"subject": "e1"
},
{
"type": "founder",
"quote": "De stichter van de private stichting is Coultreon Biopharma, voornoemd.",
"value": null,
"object": "e1",
"subject": "e2"
},
{
"type": "purpose",
"quote": "Artikel 7. Doel \u2013 Voorwerp 7.1. ... 7.2. ...",
"value": "De private stichting wordt opgericht ter verwezenlijking van het volgend belangeloos doel: het bevorderen van een stabiel aandeelhouderschap van Coultreon Biopharma, met het oog op een effici\u00EBnte en eenvoudige besluitvorming binnen Coultreon Biopharma (waarvan de Aandelen worden gecertificeerd overeenkomstig de voorwaarden zoals bepaald in de Administratievoorwaarden en de Aandeelhoudersovereenkomt). De private stichting beoogt met deze structuur een duurzame scheiding tot stand te brengen tussen de economische gerechtigheid tot de Aandelen en de uitoefening van de daaraan verbonden zeggenschapsrechten. De private stichting zal fungeren als administratiekantoor van de Aandelen van Coultreon Biopharma.",
"object": null,
"subject": "e1"
},
{
"date": "2027-12-31",
"type": "first_fiscal_year",
"quote": "Het eerste boekjaar is een verlengd boekjaar dat aanvangt op de dag dat de private stichting rechtspersoonlijkheid verwerft en eindigt op 31 december 2027.",
"value": "31-12-2027",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-31",
"type": "officer_appointment",
"quote": "De stichter benoemt als bestuurders voor onbepaalde duur: - Pierre Raboisson BV",
"value": {
"role": "bestuurder",
"term": "onbepaalde duur",
"start_date": "2026-07-31"
},
"object": "e1",
"subject": "e3",
"_value_raw": {
"role": "bestuurder",
"term": "onbepaalde duur",
"start_date": "31-07-2026"
}
},
{
"type": "permanent_representative",
"quote": "Pierre Raboisson BV ... (met als vaste vertegenwoordiger de heer Pierre RABOISSON",
"value": null,
"object": "e3",
"subject": "e4"
},
{
"date": "2026-07-31",
"type": "officer_appointment",
"quote": "De stichter benoemt als bestuurders voor onbepaalde duur: ... - Vuldex Consulting BV",
"value": {
"role": "bestuurder",
"term": "onbepaalde duur",
"start_date": "2026-07-31"
},
"object": "e1",
"subject": "e5",
"_value_raw": {
"role": "bestuurder",
"term": "onbepaalde duur",
"start_date": "31-07-2026"
}
},
{
"type": "permanent_representative",
"quote": "Vuldex Consulting BV ... (met als vaste vertegenwoordiger Marie DE VULDER",
"value": null,
"object": "e5",
"subject": "e6"
},
{
"date": "2026-07-31",
"type": "officer_appointment",
"quote": "De stichter benoemt als bestuurders voor onbepaalde duur: ... - SKJ Consult BV",
"value": {
"role": "bestuurder",
"term": "onbepaalde duur",
"start_date": "2026-07-31"
},
"object": "e1",
"subject": "e7",
"_value_raw": {
"role": "bestuurder",
"term": "onbepaalde duur",
"start_date": "31-07-2026"
}
},
{
"type": "permanent_representative",
"quote": "SKJ Consult BV ... (met als vaste vertegenwoordiger Guy PEETERS",
"value": null,
"object": "e7",
"subject": "e8"
},
{
"type": "mandate_compensation",
"quote": "Hun opdracht wordt niet vergoed.",
"value": "onbezoldigd",
"object": "e1",
"subject": "e3"
},
{
"type": "mandate_compensation",
"quote": "Hun opdracht wordt niet vergoed.",
"value": "onbezoldigd",
"object": "e1",
"subject": "e5"
},
{
"type": "mandate_compensation",
"quote": "Hun opdracht wordt niet vergoed.",
"value": "onbezoldigd",
"object": "e1",
"subject": "e7"
},
{
"type": "filing_representative",
"quote": "De oprichters verlenen bijzondere volmacht aan David HAEX, Tonya AELBRECHT, Violette KEPPENNE, Karen CALVO VLEUGELS en Ga\u00EBtan CNOPS, advocaten bij Osborne Clarke BV ... teneinde de vervulling van de formaliteiten bij het rechtspersonenregister alsook bij een ondernemingsloket met het oog op de inschrijving van de gegevens van de private stichting in de Kruispuntbank van Ondernemingen, te verzekeren.",
"value": "vervulling van de formaliteiten bij het rechtspersonenregister alsook bij een ondernemingsloket met het oog op de inschrijving van de gegevens van de private stichting in de Kruispuntbank van Ondernemingen",
"object": "e1",
"subject": "e9"
},
{
"type": "filing_representative",
"quote": "De stichters geven volmacht aan \u00E9\u00E9n van de notarissen van \u201CBerquin Notarissen\u201D, teneinde de noodzakelijke stappen te ondernemen met het oog op het verkrijgen van de rechtspersoonlijkheid van de vereniging en de publicatie van de statuten in de Bijlagen bij het Belgisch Staatsblad.",
"value": "het verkrijgen van de rechtspersoonlijkheid van de vereniging en de publicatie van de statuten in de Bijlagen bij het Belgisch Staatsblad",
"object": "e1",
"subject": "e10"
}
],
"act_meta": {
"outcome": "corrected",
"postfix": [
"primary company kbo missing -\u003E register 1040.853.946"
],
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 35775,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "1040.853.946",
"kind": "company",
"name": "Stichting Administratiekantoor Coultreon",
"attrs": {
"seat": "Gaston Geenslaan 3, 3001 Heverlee",
"kbo_source": "register",
"legal_form": "Private stichting",
"short_name": "STAK Coultreon"
}
},
{
"id": "e2",
"kbo": "1019.429.814",
"kind": "company",
"name": "COULTREON BIOPHARMA",
"attrs": {
"seat": "Gaston Geenslaan 3, 3001 Leuven (Heverlee)",
"short_name": "COULTREON"
}
},
{
"id": "e3",
"kbo": "1021.701.592",
"kind": "company",
"name": "Pierre Raboisson BV",
"attrs": {
"seat": "Avenue Denis Diderot 5, 1300 Wavre, Belgi\u00EB"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Pierre RABOISSON",
"attrs": {
"birth_date": "1970-09-22",
"birth_place": "Mulhouse (Frankrijk)"
}
},
{
"id": "e5",
"kbo": "1015.286.033",
"kind": "company",
"name": "Vuldex Consulting BV",
"attrs": {
"seat": "Parklaan 50, 9140 Temse, Belgi\u00EB"
}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Marie DE VULDER",
"attrs": {
"birth_date": "1985-09-30",
"birth_place": "Aalst"
}
},
{
"id": "e7",
"kbo": "1022.653.974",
"kind": "company",
"name": "SKJ Consult BV",
"attrs": {
"seat": "De Zwaantjes 4, 2390 Malle, Belgi\u00EB"
}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Guy PEETERS",
"attrs": {
"birth_date": "1977-10-14",
"birth_place": "Turnhout"
}
},
{
"id": "e9",
"kbo": null,
"kind": "org",
"name": "Osborne Clarke BV",
"attrs": {
"seat": "Marsveldplein 5, 1050 Elsene"
}
},
{
"id": "e10",
"kbo": null,
"kind": "org",
"name": "Berquin Notarissen",
"attrs": {
"seat": "Lloyd Georgelaan 11, Brussel"
}
}
]
}05-05-2026 Change in the board of directors
Technical details
{
"events": [
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pierre Raboisson",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "PIERRE RABOISSON BV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "2"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Lawrence M Blatt",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": null,
"statutory": null,
"compensated": true,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "2"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Maha Katabi",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "2"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Max Klement",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "2"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Rogier Rooswinkel",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "2"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Guy Peeters",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "SKJ CONSULT BV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Peter VERHAEGHE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "SKJ CONSULT BV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel CASIER",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "SKJ CONSULT BV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marie De Vulder",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "VULDEX CONSULTING BV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Matthieu DERYNCK",
"firm_city": null,
"firm_name": "Van Halteren Notarissen",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2026-05-05",
"filing_date": "2026-04-30",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2026-04-22",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "1019.429.814",
"name_full": "COULTREON BIOPHARMA",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Matthieu DERYNCK",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": [
"expeditie",
"verslagen",
"volmachten",
"bankattesten"
],
"corrected_publication_numac": null
}20-04-2026 Publication in the Belgian Official Gazette, Minor change
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"detected_kind": "other",
"effective_date": null,
"mandate_renewal": null,
"subject_company": {
"kbo": "1019.429.814",
"name_full": "ONCO3R THERAPEUTICS",
"legal_form": "BV"
},
"liquidation_closure": null,
"officer_designation": null,
"special_procuration": null,
"single_shareholder_declaration": null
}02-03-2026 2 directors appointed, 1 resigning
- Lawrence Blatt, Bestuurder
- SKJ Consult BV, Bestuurder
- Vuldex Consulting BV, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Vuldex Consulting BV",
"address": null,
"birth_date": null
},
"effective_date": "2025-12-12",
"evidence_quote": "De vergadering nam kennis van het ontslag van Vuldex Consulting BV, met ondernemingsnummer 1015.283.033 en zetel te Parklaan 50, 9140 Temse, vast vertegenwoordigd door Marie De Vulder wonende te Parklaan 50, 9140 Temse, als bestuurder met ingang van 12 December 2025.",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Lawrence Blatt",
"address": null,
"birth_date": null
},
"effective_date": "2025-11-20",
"evidence_quote": "De vergadering besloot met eenparigheid van stemmen om Lawrence Blatt, met Amerikaanse nationaliteit en met adres voor doeleinden van dit mandaat kiezende en dit conform artikel 28 van de statuten te Gaston Geenslaan 3, 3001 Leuven, te benoemen als bestuurder van de vennootschap met ingang van 20 no"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SKJ Consult BV",
"address": null,
"birth_date": null
},
"effective_date": "2025-12-12",
"evidence_quote": "De vergadering besloot met eenparigheid van stemmen om aan SKJ Consult BV, met ondernemingsnummer 1022.653.974 en zetel te De Zwaantjes 4, 2390 Malle, vast vertegenwoordigd door Guy Peeters, wonende te De Zwaantjes 4, 2390 Malle te benoemen als bestuurder/CFO van de Vennootschap met ingang van 12 De"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1019.429.814",
"name_full": "ONCO3R THERAPEUTICS",
"legal_form": "BV"
}
}01-12-2025 2 directors appointed
- Pierre Raboisson, Gedelegeerd bestuurder
- Marie De Vulder, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Pierre Raboisson",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Pierre Raboisson BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-06-01",
"evidence_quote": "De vergadering besliste met eenparigheid van stemmen om Pierre Raboisson BV met zetel te Avenue Denis Diderot 5, 1300 Wavre, vast vertegenwoordigd door Pierre Raboisson wonende te Avenue Denis Diderot 5, 1300 Wavre, te benoemen als gedelegeerd bestuurder / CEO van de Vennootschap met ingang vanaf 1 "
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marie De Vulder",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Vuldex Consulting BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-06-01",
"evidence_quote": "De vergadering besliste met eenparigheid van stemmen om Vuldex Consulting BV met zetel te Parklaan 50, 9140 Temse, vast vertegenwoordigd door Marie De Vulder wonende te Parklaan 50, 9140 Temse, te benoemen als bestuurder en als Chief Legal Officer van de Vennootschap met ingang vanaf 1 juni 2025 en "
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1019.429.814",
"name_full": "ONCO3R THERAPEUTICS",
"legal_form": "BV"
}
}17-06-2025 Pierre Raboisson appointed as director
- Pierre Raboisson, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pierre Raboisson",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "PIERRE RABOISSON BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-04-01",
"evidence_quote": "De vergadering besliste met eenparigheid van stemmen om PIERRE RABOISSON BV te benoemen als bestuurder van Onco3R Therapeutics BV met ingang vanaf 1 april 2025. De vergadering nam kennis dat de heer Pierre Raboisson werd aangeduid om als vast vertegenwoordiger te ageren van PIERRE RABOISSON BV bij h"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1019.429.814",
"name_full": "ONCO3R THERAPEUTICS",
"legal_form": "BV"
}
}03-02-2025 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "Barricadenplein 13, 1000 Brussel",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Pierre Raboisson",
"niss": null,
"address": "Avenue Denis Diderot 5, 1300 Waver"
},
"share_class": "Aandelen op naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 17000,
"holder_person_name": "Pierre Raboisson",
"is_subscriber_only": false,
"n_shares_subscribed": 170,
"amount_subscribed_eur": 17000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Pieter Peeters",
"niss": null,
"address": "Dijkstraat 42, 2480 Dessel"
},
"share_class": "Aandelen op naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 15000,
"holder_person_name": "Pieter Peeters",
"is_subscriber_only": false,
"n_shares_subscribed": 150,
"amount_subscribed_eur": 15000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Francois Gonzalvez",
"niss": null,
"address": "Raketlaan 14, 1150 Sint-Pieters-Woluwe"
},
"share_class": "Aandelen op naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 15000,
"holder_person_name": "Francois Gonzalvez",
"is_subscriber_only": false,
"n_shares_subscribed": 150,
"amount_subscribed_eur": 15000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Marie De Vulder",
"niss": null,
"address": "Parklaan 50, 9140 Temse"
},
"share_class": "Aandelen op naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 15000,
"holder_person_name": "Marie De Vulder",
"is_subscriber_only": false,
"n_shares_subscribed": 150,
"amount_subscribed_eur": 15000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Joost Kolkman",
"niss": null,
"address": "Berkenlaan 7, 3951XW Maarn, Nederland"
},
"share_class": "Aandelen op naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 8000,
"holder_person_name": "Joost Kolkman",
"is_subscriber_only": false,
"n_shares_subscribed": 80,
"amount_subscribed_eur": 8000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Sandrine Vendeville",
"niss": null,
"address": "Bemelstraat 142, 1150 Sint-Pieters-Woluwe"
},
"share_class": "Aandelen op naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 8000,
"holder_person_name": "Sandrine Vendeville",
"is_subscriber_only": false,
"n_shares_subscribed": 80,
"amount_subscribed_eur": 8000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 78000,
"subject_company": {
"kbo": "1019.429.814",
"name_full": "ONCO3R Therapeutics",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2025-01-24",
"post_incorporation_mandates": []
}| Legal nameNL | COULTREON BIOPHARMA |
| Legal nameNL | ONCO3R Therapeutics |
| AbbreviationNL | COULTREON |